Filing Details

Accession Number:
0001140361-17-029595
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-08-01 16:23:20
Reporting Period:
2017-08-01
Filing Date:
2017-08-01
Accepted Time:
2017-08-01 16:23:20
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1656328 Sienna Biopharmaceuticals Inc. SNNA Pharmaceutical Preparations (2834) 273364627
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1711462 F. Paul Lizzul C/O Sienna Biopharmaceuticals, Inc.
30699 Russell Ranch Road, Suite 140
Westlake Village CA 91362
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-08-01 10,557 $0.00 10,557 No 4 C Indirect See Footnote
Common Stock Acquisiton 2017-08-01 10,000 $15.00 94,634 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Indirect See Footnote
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series A-3 Preferred Stock Disposition 2017-08-01 10,557 $0.00 10,557 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Indirect
Footnotes
  1. The shares of the Issuer's Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, on a 1:1 basis immediately prior to the consummation of the Issuer's initial public offering.
  2. The shares are directly held by the Lizzul Living Trust, Paul F. Lizzul and Dawn Marie Lizzul, Trustees.
  3. The Reporting Person purchased the shares of the Issuer's common stock in connection with the Issuer's initial public offering at the offering price of $15.00 per share.
  4. The expiration date is not relevant to the conversion of these securities.